These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21917849)

  • 21. Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?
    Catafau AM; Bullich S; Seibyl JP; Barthel H; Ghetti B; Leverenz J; Ironside JW; Schulz-Schaeffer WJ; Hoffmann A; Sabri O
    J Nucl Med; 2016 Nov; 57(11):1740-1745. PubMed ID: 27363836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
    Sabri O; Sabbagh MN; Seibyl J; Barthel H; Akatsu H; Ouchi Y; Senda K; Murayama S; Ishii K; Takao M; Beach TG; Rowe CC; Leverenz JB; Ghetti B; Ironside JW; Catafau AM; Stephens AW; Mueller A; Koglin N; Hoffmann A; Roth K; Reininger C; Schulz-Schaeffer WJ;
    Alzheimers Dement; 2015 Aug; 11(8):964-74. PubMed ID: 25824567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid imaging with PET in early Alzheimer disease diagnosis.
    Rowe CC; Villemagne VL
    Med Clin North Am; 2013 May; 97(3):377-98. PubMed ID: 23642577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
    Choi H; Jin KH;
    Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.
    Rowe CC; Ackerman U; Browne W; Mulligan R; Pike KL; O'Keefe G; Tochon-Danguy H; Chan G; Berlangieri SU; Jones G; Dickinson-Rowe KL; Kung HP; Zhang W; Kung MP; Skovronsky D; Dyrks T; Holl G; Krause S; Friebe M; Lehman L; Lindemann S; Dinkelborg LM; Masters CL; Villemagne VL
    Lancet Neurol; 2008 Feb; 7(2):129-35. PubMed ID: 18191617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid Imaging: Poised for Integration into Medical Practice.
    Anand K; Sabbagh M
    Neurotherapeutics; 2017 Jan; 14(1):54-61. PubMed ID: 27571940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular PET imaging for in vivo detection of amyloid in the human brain].
    Okamura N
    Rinsho Shinkeigaku; 2009 Nov; 49(11):922-4. PubMed ID: 20030249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
    de Lartigue J
    Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
    Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B
    Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
    Barthel H; Meyer PT; Drzezga A; Bartenstein P; Boecker H; Brust P; Buchert R; Coenen HH; la Fougère C; Gründer G; Grünwald F; Krause BJ; Kuwert T; Schreckenberger M; Tatsch K; Langen KJ; Sabri O
    Nuklearmedizin; 2016 Aug; 55(4):129-37. PubMed ID: 27080914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images.
    Carbonell F; Zijdenbos AP; Charil A; Grand'Maison M; Bedell BJ;
    J Nucl Med; 2015 Sep; 56(9):1351-8. PubMed ID: 26135108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Zeng F; Goodman MM
    Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.